Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Hoskin P"'
Autor:
Navarro-Domenech I; Radiation Medicine Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada., Behroozian T; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada., Hoskin P; Mount Vernon Cancer Centre, Northwood, United Kingdom; Division of Cancer Sciences, University of Manchester, Manchester, UK., Johnstone C; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., Recht A; Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA., Menten J; Department of Radiation Oncology, University Hospital Leuven, Leuven, Belgium., Oldenburger E; Department of Radiation Oncology, University Hospital Leuven, Leuven, Belgium., van der Linden YM; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, and Leiden University Medical Center, Leiden, The Netherlands., van der Velden JM; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, and Leiden University Medical Center, Leiden, The Netherlands., Nguyen QN; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Simone CB 2nd; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Johnstone P; Department of Health Outcomes and Behavior and Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Lutz S; Eastern Woods Radiation Oncology, Blanchard Valley Health Organization, Findlay, OH, USA., Milton L; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada., Andratschke N; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Willmann J; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Kazmierska J; Radiotherapy Department II, Greater Poland Cancer Centre, Poznan, Poland; Department of Electroradiology, Poznań University of Medical Sciences, Poznań, Poland., Spałek M; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland; Department of Radiotherapy I, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Marta GN; Department of Radiation Oncology, Hospital Sírio-Libanês, Sao Paulo, Brazil., Chow E; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada., Raman S; Radiation Medicine Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
Publikováno v:
Annals of palliative medicine [Ann Palliat Med] 2023 May; Vol. 12 (3), pp. 620-632. Date of Electronic Publication: 2023 Apr 12.
Autor:
Raman S; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada., Ding K; Canadian Cancer Trials Group, Cancer Research Institute, Queen's University, Kingston, ON, Canada., Chow E; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada. edward.chow@sunnybrook.ca., Meyer RM; Juravinski Hospital and Cancer Centre and McMaster University, Hamilton, ON, Canada., van der Linden YM; Leiden University Medical Centre, Leiden and Radiotherapy Institute Friesland, Leeuwarden, The Netherlands., Roos D; Royal Adelaide Hospital, University of Adelaide, Adelaide, Australia., Hartsell WF; Northwestern Medicine Central DuPage Hospital, Warrenville, IL, USA., Hoskin P; Mount Vernon Hospital Cancer Centre, Middlesex, UK., Wu JSY; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., Nabid A; Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada., Haas R; Netherlands Cancer Institute / Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Wiggenraad R; HMC, The Hague, Netherlands., Babington S; Christchurch Hospital, Christchurch, New Zealand., Demas WF; Akron City Hospital, Northeast Ohio Medical University, Akron, OH, USA., Wilson CF; Canadian Cancer Trials Group, Cancer Research Institute, Queen's University, Kingston, ON, Canada., Wong RKS; Princess Margaret Cancer Centre, Radiation Medicine Program, Ontario Cancer Institute University of Toronto, Toronto, ON, Canada., Zhu L; Canadian Cancer Trials Group, Cancer Research Institute, Queen's University, Kingston, ON, Canada., Brundage M; Queen's University, Kingston, ON, Canada.
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2018 Apr; Vol. 27 (4), pp. 1089-1098. Date of Electronic Publication: 2017 Nov 29.
Autor:
Chow R; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Canada., Hoskin P; Mount Vernon Hospital, Imperial College, London, United Kingdom., Chan S; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Canada., Mesci A; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Canada., Hollenberg D; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Canada., Lam H; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Canada., DeAngelis C; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Canada., Chow E; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Canada. Electronic address: edward.chow@sunnybrook.ca.
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2017 Mar; Vol. 122 (3), pp. 323-331. Date of Electronic Publication: 2017 Jan 12.
Autor:
Chow E; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada. Edward.Chow@sunnybrook.ca.; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada. Edward.Chow@sunnybrook.ca., Ding K; NCIC Clinical Trials Group, Cancer Research Institute, Queen's University, Kingston, ON, Canada., Parulekar WR; NCIC Clinical Trials Group, Cancer Research Institute, Queen's University, Kingston, ON, Canada., Wong RK; Princess Margaret Cancer Centre, Radiation Medicine Program, Ontario Cancer Institute, University of Toronto, Toronto, ON, Canada., van der Linden YM; Leiden University Medical Centre, Leiden and Radiotherapy Institute Friesland, Leeuwarden, Netherlands., Roos D; Royal Adelaide Hospital, University of Adelaide, Adelaide, Australia., Hartsell WF; Central DuPage Hospital Cancer Center, Warrenville, IL, USA., Hoskin P; Mount Vernon Hospital Cancer Centre, Middlesex, UK., Wu JS; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., Nabid A; Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada., Ong F; Medisch Spectrum Twente, Enschede, Netherlands., van Tienhoven G; Academic Medical Center, Amsterdam, Netherlands., Babington S; Christchurch Hospital, Christchurch, New Zealand., Demas WF; Akron City Hospital, Northeast Ohio Medical University, Akron, OH, USA., Wilson CF; NCIC Clinical Trials Group, Cancer Research Institute, Queen's University, Kingston, ON, Canada., Brundage M; Queen's University, Kingston, ON, Canada., Zhu L; NCIC Clinical Trials Group, Cancer Research Institute, Queen's University, Kingston, ON, Canada., Meyer RM; Juravinski Hospital and Cancer Centre and McMaster University, Hamilton, ON, Canada.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2016 Apr; Vol. 24 (4), pp. 1617-23. Date of Electronic Publication: 2015 Sep 23.
Autor:
Hoskin P; Mount Vernon Cancer Center, Northwood, UK (PH); Nottingham University Hospitals NHS Trust, Nottingham, UK (SS); Cancer Research UK & UCL Cancer Trials Center, London, UK (KR, SF, AK MJ, AH); Kent & Canterbury Hospital, Canterbury, UK (NM); Essex County Hospital, Colchester, UK (BS); Royal Sussex County Hospital, Brighton, UK (DB); Scunthorpe General Hospital, Scunthorpe, UK (SU); Bristol Haematology & Oncology Center, Bristol, UK (PW); CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, UK (MS). peterhoskin@nhs.net., Sundar S; Mount Vernon Cancer Center, Northwood, UK (PH); Nottingham University Hospitals NHS Trust, Nottingham, UK (SS); Cancer Research UK & UCL Cancer Trials Center, London, UK (KR, SF, AK MJ, AH); Kent & Canterbury Hospital, Canterbury, UK (NM); Essex County Hospital, Colchester, UK (BS); Royal Sussex County Hospital, Brighton, UK (DB); Scunthorpe General Hospital, Scunthorpe, UK (SU); Bristol Haematology & Oncology Center, Bristol, UK (PW); CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, UK (MS)., Reczko K; Mount Vernon Cancer Center, Northwood, UK (PH); Nottingham University Hospitals NHS Trust, Nottingham, UK (SS); Cancer Research UK & UCL Cancer Trials Center, London, UK (KR, SF, AK MJ, AH); Kent & Canterbury Hospital, Canterbury, UK (NM); Essex County Hospital, Colchester, UK (BS); Royal Sussex County Hospital, Brighton, UK (DB); Scunthorpe General Hospital, Scunthorpe, UK (SU); Bristol Haematology & Oncology Center, Bristol, UK (PW); CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, UK (MS)., Forsyth S; Mount Vernon Cancer Center, Northwood, UK (PH); Nottingham University Hospitals NHS Trust, Nottingham, UK (SS); Cancer Research UK & UCL Cancer Trials Center, London, UK (KR, SF, AK MJ, AH); Kent & Canterbury Hospital, Canterbury, UK (NM); Essex County Hospital, Colchester, UK (BS); Royal Sussex County Hospital, Brighton, UK (DB); Scunthorpe General Hospital, Scunthorpe, UK (SU); Bristol Haematology & Oncology Center, Bristol, UK (PW); CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, UK (MS)., Mithal N; Mount Vernon Cancer Center, Northwood, UK (PH); Nottingham University Hospitals NHS Trust, Nottingham, UK (SS); Cancer Research UK & UCL Cancer Trials Center, London, UK (KR, SF, AK MJ, AH); Kent & Canterbury Hospital, Canterbury, UK (NM); Essex County Hospital, Colchester, UK (BS); Royal Sussex County Hospital, Brighton, UK (DB); Scunthorpe General Hospital, Scunthorpe, UK (SU); Bristol Haematology & Oncology Center, Bristol, UK (PW); CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, UK (MS)., Sizer B; Mount Vernon Cancer Center, Northwood, UK (PH); Nottingham University Hospitals NHS Trust, Nottingham, UK (SS); Cancer Research UK & UCL Cancer Trials Center, London, UK (KR, SF, AK MJ, AH); Kent & Canterbury Hospital, Canterbury, UK (NM); Essex County Hospital, Colchester, UK (BS); Royal Sussex County Hospital, Brighton, UK (DB); Scunthorpe General Hospital, Scunthorpe, UK (SU); Bristol Haematology & Oncology Center, Bristol, UK (PW); CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, UK (MS)., Bloomfield D; Mount Vernon Cancer Center, Northwood, UK (PH); Nottingham University Hospitals NHS Trust, Nottingham, UK (SS); Cancer Research UK & UCL Cancer Trials Center, London, UK (KR, SF, AK MJ, AH); Kent & Canterbury Hospital, Canterbury, UK (NM); Essex County Hospital, Colchester, UK (BS); Royal Sussex County Hospital, Brighton, UK (DB); Scunthorpe General Hospital, Scunthorpe, UK (SU); Bristol Haematology & Oncology Center, Bristol, UK (PW); CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, UK (MS)., Upadhyay S; Mount Vernon Cancer Center, Northwood, UK (PH); Nottingham University Hospitals NHS Trust, Nottingham, UK (SS); Cancer Research UK & UCL Cancer Trials Center, London, UK (KR, SF, AK MJ, AH); Kent & Canterbury Hospital, Canterbury, UK (NM); Essex County Hospital, Colchester, UK (BS); Royal Sussex County Hospital, Brighton, UK (DB); Scunthorpe General Hospital, Scunthorpe, UK (SU); Bristol Haematology & Oncology Center, Bristol, UK (PW); CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, UK (MS)., Wilson P; Mount Vernon Cancer Center, Northwood, UK (PH); Nottingham University Hospitals NHS Trust, Nottingham, UK (SS); Cancer Research UK & UCL Cancer Trials Center, London, UK (KR, SF, AK MJ, AH); Kent & Canterbury Hospital, Canterbury, UK (NM); Essex County Hospital, Colchester, UK (BS); Royal Sussex County Hospital, Brighton, UK (DB); Scunthorpe General Hospital, Scunthorpe, UK (SU); Bristol Haematology & Oncology Center, Bristol, UK (PW); CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, UK (MS)., Kirkwood A; Mount Vernon Cancer Center, Northwood, UK (PH); Nottingham University Hospitals NHS Trust, Nottingham, UK (SS); Cancer Research UK & UCL Cancer Trials Center, London, UK (KR, SF, AK MJ, AH); Kent & Canterbury Hospital, Canterbury, UK (NM); Essex County Hospital, Colchester, UK (BS); Royal Sussex County Hospital, Brighton, UK (DB); Scunthorpe General Hospital, Scunthorpe, UK (SU); Bristol Haematology & Oncology Center, Bristol, UK (PW); CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, UK (MS)., Stratford M; Mount Vernon Cancer Center, Northwood, UK (PH); Nottingham University Hospitals NHS Trust, Nottingham, UK (SS); Cancer Research UK & UCL Cancer Trials Center, London, UK (KR, SF, AK MJ, AH); Kent & Canterbury Hospital, Canterbury, UK (NM); Essex County Hospital, Colchester, UK (BS); Royal Sussex County Hospital, Brighton, UK (DB); Scunthorpe General Hospital, Scunthorpe, UK (SU); Bristol Haematology & Oncology Center, Bristol, UK (PW); CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, UK (MS)., Jitlal M; Mount Vernon Cancer Center, Northwood, UK (PH); Nottingham University Hospitals NHS Trust, Nottingham, UK (SS); Cancer Research UK & UCL Cancer Trials Center, London, UK (KR, SF, AK MJ, AH); Kent & Canterbury Hospital, Canterbury, UK (NM); Essex County Hospital, Colchester, UK (BS); Royal Sussex County Hospital, Brighton, UK (DB); Scunthorpe General Hospital, Scunthorpe, UK (SU); Bristol Haematology & Oncology Center, Bristol, UK (PW); CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, UK (MS)., Hackshaw A; Mount Vernon Cancer Center, Northwood, UK (PH); Nottingham University Hospitals NHS Trust, Nottingham, UK (SS); Cancer Research UK & UCL Cancer Trials Center, London, UK (KR, SF, AK MJ, AH); Kent & Canterbury Hospital, Canterbury, UK (NM); Essex County Hospital, Colchester, UK (BS); Royal Sussex County Hospital, Brighton, UK (DB); Scunthorpe General Hospital, Scunthorpe, UK (SU); Bristol Haematology & Oncology Center, Bristol, UK (PW); CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, UK (MS).
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2015 Aug 04; Vol. 107 (10). Date of Electronic Publication: 2015 Aug 04 (Print Publication: 2015).
Autor:
Hoskin P; Cancer Centre, Mount Vernon Hospital, UK., Rojas A; Cancer Centre, Mount Vernon Hospital, UK. Electronic address: arc03@btconnect.com., Fidarova E; IAEA, Division of Human Health, Vienna, Austria., Jalali R; Tata Memorial Hospital, Mumbai, India., Mena Merino A; Hospital Son Dureta, Palmas de Mallorca, Spain., Poitevin A; Instituto Nacional Cancerología, México DF, Mexico., Oucrif S; Dep. Radiothérapie, Centre Hospitalier Universitaire, Alger, Algeria., Abdelwahab S; Misr Oncology Centre, Cairo, Egypt., Kochbati L; Radiotherapie carcinologique, Institut Salah Azaiz, Tunis, Tunisia., Plieskiene A; Institute of Oncology, Vilnius University, Lithuania., Casas F; Radiation Oncology, Hospital Clínic i Universitari, Barcelona, Spain., Stojanovic S; Institute of Oncology & Radiology, Belgrade, Serbia., Schneider G; Fundacao Faculdade Federal de Ciencias Medicas, Porto Alegre, Brazil., Jeremic B; IAEA, Division of Human Health, Vienna, Austria.
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2015 Jul; Vol. 116 (1), pp. 10-4. Date of Electronic Publication: 2015 May 27.
Autor:
Kane CM; Academic Unit of Palliative Care, Leeds Institute of Health Sciences, School of Medicine, University of Leeds, Leeds, UK Christopher.Kane@nhs.net., Hoskin P; Mount Vernon Cancer Centre, Northwood, University College London, London, UK., Bennett MI; Academic Unit of Palliative Care, Leeds Institute of Health Sciences, School of Medicine, University of Leeds, Leeds, UK.
Publikováno v:
BMJ (Clinical research ed.) [BMJ] 2015 Jan 29; Vol. 350, pp. h315. Date of Electronic Publication: 2015 Jan 29.
Autor:
Chow E; Edward Chow, Sunnybrook Odette Cancer Centre, University of Toronto; Rebecca K.S. Wong, Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, Toronto; Ralph M. Meyer, Juravinski Hospital and Cancer Centre and McMaster University, Hamilton; Bingshu E. Chen, Carolyn F. Wilson, and Michael Brundage, Cancer Research Institute, Queen's University, Kingston, Ontario; Jackson S.Y. Wu, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta; Abdenour Nabid, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada; Yvette M. van der Linden, Leiden University Medical Centre, Leiden and Radiotherapy Institute Friesland, Leeuwarden; Caroline J.A. Tissing-Tan, Institute for Radiation Oncology Arnhem, Arnhem; Bing Oei, Dr Bernard Verbeeten Instituut, Tilburg, the Netherlands; Daniel Roos, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia; William F. Hartsell, Central DuPage Hospital Cancer Center, Warrenville, IL; Peter Hoskin, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom; Scott Babington, Christchurch Hospital, Christchurch, New Zealand; and William F. Demas, Akron City Hospital, Northeast Ohio Medical University, Akron, OH. edward.chow@sunnybrook.ca., Meyer RM; Edward Chow, Sunnybrook Odette Cancer Centre, University of Toronto; Rebecca K.S. Wong, Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, Toronto; Ralph M. Meyer, Juravinski Hospital and Cancer Centre and McMaster University, Hamilton; Bingshu E. Chen, Carolyn F. Wilson, and Michael Brundage, Cancer Research Institute, Queen's University, Kingston, Ontario; Jackson S.Y. Wu, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta; Abdenour Nabid, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada; Yvette M. van der Linden, Leiden University Medical Centre, Leiden and Radiotherapy Institute Friesland, Leeuwarden; Caroline J.A. Tissing-Tan, Institute for Radiation Oncology Arnhem, Arnhem; Bing Oei, Dr Bernard Verbeeten Instituut, Tilburg, the Netherlands; Daniel Roos, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia; William F. Hartsell, Central DuPage Hospital Cancer Center, Warrenville, IL; Peter Hoskin, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom; Scott Babington, Christchurch Hospital, Christchurch, New Zealand; and William F. Demas, Akron City Hospital, Northeast Ohio Medical University, Akron, OH., Chen BE; Edward Chow, Sunnybrook Odette Cancer Centre, University of Toronto; Rebecca K.S. Wong, Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, Toronto; Ralph M. Meyer, Juravinski Hospital and Cancer Centre and McMaster University, Hamilton; Bingshu E. Chen, Carolyn F. Wilson, and Michael Brundage, Cancer Research Institute, Queen's University, Kingston, Ontario; Jackson S.Y. Wu, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta; Abdenour Nabid, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada; Yvette M. van der Linden, Leiden University Medical Centre, Leiden and Radiotherapy Institute Friesland, Leeuwarden; Caroline J.A. Tissing-Tan, Institute for Radiation Oncology Arnhem, Arnhem; Bing Oei, Dr Bernard Verbeeten Instituut, Tilburg, the Netherlands; Daniel Roos, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia; William F. Hartsell, Central DuPage Hospital Cancer Center, Warrenville, IL; Peter Hoskin, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom; Scott Babington, Christchurch Hospital, Christchurch, New Zealand; and William F. Demas, Akron City Hospital, Northeast Ohio Medical University, Akron, OH., van der Linden YM; Edward Chow, Sunnybrook Odette Cancer Centre, University of Toronto; Rebecca K.S. Wong, Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, Toronto; Ralph M. Meyer, Juravinski Hospital and Cancer Centre and McMaster University, Hamilton; Bingshu E. Chen, Carolyn F. Wilson, and Michael Brundage, Cancer Research Institute, Queen's University, Kingston, Ontario; Jackson S.Y. Wu, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta; Abdenour Nabid, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada; Yvette M. van der Linden, Leiden University Medical Centre, Leiden and Radiotherapy Institute Friesland, Leeuwarden; Caroline J.A. Tissing-Tan, Institute for Radiation Oncology Arnhem, Arnhem; Bing Oei, Dr Bernard Verbeeten Instituut, Tilburg, the Netherlands; Daniel Roos, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia; William F. Hartsell, Central DuPage Hospital Cancer Center, Warrenville, IL; Peter Hoskin, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom; Scott Babington, Christchurch Hospital, Christchurch, New Zealand; and William F. Demas, Akron City Hospital, Northeast Ohio Medical University, Akron, OH., Roos D; Edward Chow, Sunnybrook Odette Cancer Centre, University of Toronto; Rebecca K.S. Wong, Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, Toronto; Ralph M. Meyer, Juravinski Hospital and Cancer Centre and McMaster University, Hamilton; Bingshu E. Chen, Carolyn F. Wilson, and Michael Brundage, Cancer Research Institute, Queen's University, Kingston, Ontario; Jackson S.Y. Wu, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta; Abdenour Nabid, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada; Yvette M. van der Linden, Leiden University Medical Centre, Leiden and Radiotherapy Institute Friesland, Leeuwarden; Caroline J.A. Tissing-Tan, Institute for Radiation Oncology Arnhem, Arnhem; Bing Oei, Dr Bernard Verbeeten Instituut, Tilburg, the Netherlands; Daniel Roos, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia; William F. Hartsell, Central DuPage Hospital Cancer Center, Warrenville, IL; Peter Hoskin, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom; Scott Babington, Christchurch Hospital, Christchurch, New Zealand; and William F. Demas, Akron City Hospital, Northeast Ohio Medical University, Akron, OH., Hartsell WF; Edward Chow, Sunnybrook Odette Cancer Centre, University of Toronto; Rebecca K.S. Wong, Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, Toronto; Ralph M. Meyer, Juravinski Hospital and Cancer Centre and McMaster University, Hamilton; Bingshu E. Chen, Carolyn F. Wilson, and Michael Brundage, Cancer Research Institute, Queen's University, Kingston, Ontario; Jackson S.Y. Wu, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta; Abdenour Nabid, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada; Yvette M. van der Linden, Leiden University Medical Centre, Leiden and Radiotherapy Institute Friesland, Leeuwarden; Caroline J.A. Tissing-Tan, Institute for Radiation Oncology Arnhem, Arnhem; Bing Oei, Dr Bernard Verbeeten Instituut, Tilburg, the Netherlands; Daniel Roos, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia; William F. Hartsell, Central DuPage Hospital Cancer Center, Warrenville, IL; Peter Hoskin, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom; Scott Babington, Christchurch Hospital, Christchurch, New Zealand; and William F. Demas, Akron City Hospital, Northeast Ohio Medical University, Akron, OH., Hoskin P; Edward Chow, Sunnybrook Odette Cancer Centre, University of Toronto; Rebecca K.S. Wong, Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, Toronto; Ralph M. Meyer, Juravinski Hospital and Cancer Centre and McMaster University, Hamilton; Bingshu E. Chen, Carolyn F. Wilson, and Michael Brundage, Cancer Research Institute, Queen's University, Kingston, Ontario; Jackson S.Y. Wu, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta; Abdenour Nabid, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada; Yvette M. van der Linden, Leiden University Medical Centre, Leiden and Radiotherapy Institute Friesland, Leeuwarden; Caroline J.A. Tissing-Tan, Institute for Radiation Oncology Arnhem, Arnhem; Bing Oei, Dr Bernard Verbeeten Instituut, Tilburg, the Netherlands; Daniel Roos, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia; William F. Hartsell, Central DuPage Hospital Cancer Center, Warrenville, IL; Peter Hoskin, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom; Scott Babington, Christchurch Hospital, Christchurch, New Zealand; and William F. Demas, Akron City Hospital, Northeast Ohio Medical University, Akron, OH., Wu JS; Edward Chow, Sunnybrook Odette Cancer Centre, University of Toronto; Rebecca K.S. Wong, Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, Toronto; Ralph M. Meyer, Juravinski Hospital and Cancer Centre and McMaster University, Hamilton; Bingshu E. Chen, Carolyn F. Wilson, and Michael Brundage, Cancer Research Institute, Queen's University, Kingston, Ontario; Jackson S.Y. Wu, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta; Abdenour Nabid, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada; Yvette M. van der Linden, Leiden University Medical Centre, Leiden and Radiotherapy Institute Friesland, Leeuwarden; Caroline J.A. Tissing-Tan, Institute for Radiation Oncology Arnhem, Arnhem; Bing Oei, Dr Bernard Verbeeten Instituut, Tilburg, the Netherlands; Daniel Roos, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia; William F. Hartsell, Central DuPage Hospital Cancer Center, Warrenville, IL; Peter Hoskin, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom; Scott Babington, Christchurch Hospital, Christchurch, New Zealand; and William F. Demas, Akron City Hospital, Northeast Ohio Medical University, Akron, OH., Nabid A; Edward Chow, Sunnybrook Odette Cancer Centre, University of Toronto; Rebecca K.S. Wong, Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, Toronto; Ralph M. Meyer, Juravinski Hospital and Cancer Centre and McMaster University, Hamilton; Bingshu E. Chen, Carolyn F. Wilson, and Michael Brundage, Cancer Research Institute, Queen's University, Kingston, Ontario; Jackson S.Y. Wu, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta; Abdenour Nabid, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada; Yvette M. van der Linden, Leiden University Medical Centre, Leiden and Radiotherapy Institute Friesland, Leeuwarden; Caroline J.A. Tissing-Tan, Institute for Radiation Oncology Arnhem, Arnhem; Bing Oei, Dr Bernard Verbeeten Instituut, Tilburg, the Netherlands; Daniel Roos, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia; William F. Hartsell, Central DuPage Hospital Cancer Center, Warrenville, IL; Peter Hoskin, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom; Scott Babington, Christchurch Hospital, Christchurch, New Zealand; and William F. Demas, Akron City Hospital, Northeast Ohio Medical University, Akron, OH., Tissing-Tan CJ; Edward Chow, Sunnybrook Odette Cancer Centre, University of Toronto; Rebecca K.S. Wong, Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, Toronto; Ralph M. Meyer, Juravinski Hospital and Cancer Centre and McMaster University, Hamilton; Bingshu E. Chen, Carolyn F. Wilson, and Michael Brundage, Cancer Research Institute, Queen's University, Kingston, Ontario; Jackson S.Y. Wu, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta; Abdenour Nabid, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada; Yvette M. van der Linden, Leiden University Medical Centre, Leiden and Radiotherapy Institute Friesland, Leeuwarden; Caroline J.A. Tissing-Tan, Institute for Radiation Oncology Arnhem, Arnhem; Bing Oei, Dr Bernard Verbeeten Instituut, Tilburg, the Netherlands; Daniel Roos, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia; William F. Hartsell, Central DuPage Hospital Cancer Center, Warrenville, IL; Peter Hoskin, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom; Scott Babington, Christchurch Hospital, Christchurch, New Zealand; and William F. Demas, Akron City Hospital, Northeast Ohio Medical University, Akron, OH., Oei B; Edward Chow, Sunnybrook Odette Cancer Centre, University of Toronto; Rebecca K.S. Wong, Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, Toronto; Ralph M. Meyer, Juravinski Hospital and Cancer Centre and McMaster University, Hamilton; Bingshu E. Chen, Carolyn F. Wilson, and Michael Brundage, Cancer Research Institute, Queen's University, Kingston, Ontario; Jackson S.Y. Wu, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta; Abdenour Nabid, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada; Yvette M. van der Linden, Leiden University Medical Centre, Leiden and Radiotherapy Institute Friesland, Leeuwarden; Caroline J.A. Tissing-Tan, Institute for Radiation Oncology Arnhem, Arnhem; Bing Oei, Dr Bernard Verbeeten Instituut, Tilburg, the Netherlands; Daniel Roos, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia; William F. Hartsell, Central DuPage Hospital Cancer Center, Warrenville, IL; Peter Hoskin, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom; Scott Babington, Christchurch Hospital, Christchurch, New Zealand; and William F. Demas, Akron City Hospital, Northeast Ohio Medical University, Akron, OH., Babington S; Edward Chow, Sunnybrook Odette Cancer Centre, University of Toronto; Rebecca K.S. Wong, Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, Toronto; Ralph M. Meyer, Juravinski Hospital and Cancer Centre and McMaster University, Hamilton; Bingshu E. Chen, Carolyn F. Wilson, and Michael Brundage, Cancer Research Institute, Queen's University, Kingston, Ontario; Jackson S.Y. Wu, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta; Abdenour Nabid, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada; Yvette M. van der Linden, Leiden University Medical Centre, Leiden and Radiotherapy Institute Friesland, Leeuwarden; Caroline J.A. Tissing-Tan, Institute for Radiation Oncology Arnhem, Arnhem; Bing Oei, Dr Bernard Verbeeten Instituut, Tilburg, the Netherlands; Daniel Roos, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia; William F. Hartsell, Central DuPage Hospital Cancer Center, Warrenville, IL; Peter Hoskin, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom; Scott Babington, Christchurch Hospital, Christchurch, New Zealand; and William F. Demas, Akron City Hospital, Northeast Ohio Medical University, Akron, OH., Demas WF; Edward Chow, Sunnybrook Odette Cancer Centre, University of Toronto; Rebecca K.S. Wong, Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, Toronto; Ralph M. Meyer, Juravinski Hospital and Cancer Centre and McMaster University, Hamilton; Bingshu E. Chen, Carolyn F. Wilson, and Michael Brundage, Cancer Research Institute, Queen's University, Kingston, Ontario; Jackson S.Y. Wu, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta; Abdenour Nabid, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada; Yvette M. van der Linden, Leiden University Medical Centre, Leiden and Radiotherapy Institute Friesland, Leeuwarden; Caroline J.A. Tissing-Tan, Institute for Radiation Oncology Arnhem, Arnhem; Bing Oei, Dr Bernard Verbeeten Instituut, Tilburg, the Netherlands; Daniel Roos, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia; William F. Hartsell, Central DuPage Hospital Cancer Center, Warrenville, IL; Peter Hoskin, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom; Scott Babington, Christchurch Hospital, Christchurch, New Zealand; and William F. Demas, Akron City Hospital, Northeast Ohio Medical University, Akron, OH., Wilson CF; Edward Chow, Sunnybrook Odette Cancer Centre, University of Toronto; Rebecca K.S. Wong, Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, Toronto; Ralph M. Meyer, Juravinski Hospital and Cancer Centre and McMaster University, Hamilton; Bingshu E. Chen, Carolyn F. Wilson, and Michael Brundage, Cancer Research Institute, Queen's University, Kingston, Ontario; Jackson S.Y. Wu, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta; Abdenour Nabid, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada; Yvette M. van der Linden, Leiden University Medical Centre, Leiden and Radiotherapy Institute Friesland, Leeuwarden; Caroline J.A. Tissing-Tan, Institute for Radiation Oncology Arnhem, Arnhem; Bing Oei, Dr Bernard Verbeeten Instituut, Tilburg, the Netherlands; Daniel Roos, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia; William F. Hartsell, Central DuPage Hospital Cancer Center, Warrenville, IL; Peter Hoskin, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom; Scott Babington, Christchurch Hospital, Christchurch, New Zealand; and William F. Demas, Akron City Hospital, Northeast Ohio Medical University, Akron, OH., Wong RK; Edward Chow, Sunnybrook Odette Cancer Centre, University of Toronto; Rebecca K.S. Wong, Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, Toronto; Ralph M. Meyer, Juravinski Hospital and Cancer Centre and McMaster University, Hamilton; Bingshu E. Chen, Carolyn F. Wilson, and Michael Brundage, Cancer Research Institute, Queen's University, Kingston, Ontario; Jackson S.Y. Wu, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta; Abdenour Nabid, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada; Yvette M. van der Linden, Leiden University Medical Centre, Leiden and Radiotherapy Institute Friesland, Leeuwarden; Caroline J.A. Tissing-Tan, Institute for Radiation Oncology Arnhem, Arnhem; Bing Oei, Dr Bernard Verbeeten Instituut, Tilburg, the Netherlands; Daniel Roos, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia; William F. Hartsell, Central DuPage Hospital Cancer Center, Warrenville, IL; Peter Hoskin, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom; Scott Babington, Christchurch Hospital, Christchurch, New Zealand; and William F. Demas, Akron City Hospital, Northeast Ohio Medical University, Akron, OH., Brundage M; Edward Chow, Sunnybrook Odette Cancer Centre, University of Toronto; Rebecca K.S. Wong, Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, Toronto; Ralph M. Meyer, Juravinski Hospital and Cancer Centre and McMaster University, Hamilton; Bingshu E. Chen, Carolyn F. Wilson, and Michael Brundage, Cancer Research Institute, Queen's University, Kingston, Ontario; Jackson S.Y. Wu, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta; Abdenour Nabid, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada; Yvette M. van der Linden, Leiden University Medical Centre, Leiden and Radiotherapy Institute Friesland, Leeuwarden; Caroline J.A. Tissing-Tan, Institute for Radiation Oncology Arnhem, Arnhem; Bing Oei, Dr Bernard Verbeeten Instituut, Tilburg, the Netherlands; Daniel Roos, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia; William F. Hartsell, Central DuPage Hospital Cancer Center, Warrenville, IL; Peter Hoskin, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom; Scott Babington, Christchurch Hospital, Christchurch, New Zealand; and William F. Demas, Akron City Hospital, Northeast Ohio Medical University, Akron, OH.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2014 Dec 01; Vol. 32 (34), pp. 3867-73. Date of Electronic Publication: 2014 Oct 27.
Autor:
Chow E; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada. Electronic address: edward.chow@sunnybrook.ca., van der Linden YM; Leiden University Medical Centre, Leiden, Netherlands; Radiotherapy Institute Friesland, Leeuwarden, Netherlands., Roos D; Royal Adelaide Hospital, University of Adelaide, Adelaide, SA, Australia., Hartsell WF; Central DuPage Hospital Cancer Center, Warrenville, IL, USA., Hoskin P; Mount Vernon Hospital Cancer Centre, Northwood, Middlesex, UK., Wu JS; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., Brundage MD; Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute, Queen's University, Kingston, ON, Canada., Nabid A; Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada., Tissing-Tan CJ; Institute for Radiation Oncology Arnhem, Arnhem, Netherlands., Oei B; Instituut Verbeeten, Tilburg, Netherlands., Babington S; Christchurch Hospital, Christchurch, New Zealand., Demas WF; Akron City Hospital, Northeast Ohio Medical University, Akron, OH, USA., Wilson CF; NCIC Clinical Trials Group, Queen's Cancer Research Institute, Queen's University, Kingston, ON, Canada., Meyer RM; NCIC Clinical Trials Group, Queen's Cancer Research Institute, Queen's University, Kingston, ON, Canada; Department of Oncology, McMaster University, Juravinski Hospital and Cancer Centre, Hamilton, ON, Canada., Chen BE; NCIC Clinical Trials Group, Queen's Cancer Research Institute, Queen's University, Kingston, ON, Canada., Wong RK; Princess Margaret Hospital, Radiation Medicine Program, Ontario Cancer Institute, University of Toronto, Toronto, ON, Canada.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2014 Feb; Vol. 15 (2), pp. 164-71. Date of Electronic Publication: 2013 Dec 23.